Franck Gallardo

This paper validates ANCHOR viruses as a platform for evaluating disinfection methods across chemical, physical, and radiative modalities in operational conditions.

This study identifies the entry mechanisms of SG33, an oncolytic myxoma virus, into pancreatic cancer cells, showing it uses macropinocytosis and clathrin-mediated endocytosis.

This paper uses ANCHOR technology to track HPV18 genomes in live keratinocytes, showing they are randomly partitioned to daughter cells during division.

This study evaluates LAVR-289, a new antiviral compound, showing broad-spectrum activity against herpesviruses and resistance to existing treatments.

This study evaluates LAVR-289, an acyclonucleoside phosphonate, showing potent antiviral activity against adenovirus in vitro and in vivo, with 100% survival in immunocompromised hamsters.

This study evaluates LAVR-289, a nucleoside analogue, showing antiviral activity against poxviruses and ASFV in vitro and in vivo with no toxicity.